Kezar Life Sciences, Inc.·4

Jan 4, 8:45 PM ET

Fowler John Franklin 4

4 · Kezar Life Sciences, Inc. · Filed Jan 4, 2021

Insider Transaction Report

Form 4
Period: 2020-12-31
Transactions
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2020-12-3116,00090,421 total
    Exercise: $0.90Exp: 2025-09-09Common Stock (16,000 underlying)
  • Exercise/Conversion

    Common Stock

    2020-12-31$0.90/sh+16,000$14,400359,204 total
Holdings
  • Common Stock

    (indirect: By Trust)
    3,750
  • Common Stock

    (indirect: By LLC)
    38,461
Footnotes (2)
  • [F1]The reporting person is a member of Montebello Holdings LLC. The reporting person disclaims Section 16 beneficial ownership of the securities held by Montebello Holdings LLC, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
  • [F2]Fully vested.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION